Patents by Inventor Carsten Knudsen

Carsten Knudsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060194947
    Abstract: Disclosed are dipeptides that facilitate the intercellular communication mediated by gap junctions. The invention has a wide spectrum of useful applications including use in the treatment of diseases associated with impaired gap junction intracellular communication (GJIC).
    Type: Application
    Filed: November 25, 2003
    Publication date: August 31, 2006
    Inventors: Bjarne Larsen, Carsten Knudsen, Jorgen Petersen
  • Publication number: 20060194719
    Abstract: The present invention disclosed compositions comprising a stabilized Exendin-4 (1-39) and related compounds. The invention describes stabilized Exendin-4 agonists that include at least one modified amino acid residue particularly at positions Gln 13, Met14, Trp25, or Asn28 of the Exendin-4 (1-39) molecule. Disclosed are preferred modifications of deaminated, hydrolyzed, oxidized, or isomerized reaction products of the specified amino acid residues corresponding to the same positions in the Exendin-4 molecule. The invention also relates to methods of making and using the stabilized Exendin compounds, such as for the treatment of diabetes.
    Type: Application
    Filed: October 2, 2003
    Publication date: August 31, 2006
    Applicant: Zealand Pharma A/S
    Inventors: Kirsten Ebbehoj, Trine Jepsen, Carsten Knudsen, Bjarne Larsen, David Knott